Janet Maynard

Dr. Janet Maynard, as the Director of the Office of Orphan Products Development (OOPD), oversees legislatively mandated designation and grant programs intended to promote the development of products for rare diseases including, orphan drug, rare pediatric disease, and humanitarian use device designation programs, as well as clinical trial, natural history study, and pediatric device consortia grant programs. In her role, she serves as FDA’s lead in coordinating cross-cutting rare disease issues and engages extensively with patients, sponsors, and other stakeholders.